American International Group, Inc. Axcella Health Inc. Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$3.08 - $5.13 $27,797 - $46,298	-9,025 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$4.55 - $6.72 $113 - $168	25 Added 0.28%	9,025 $43,000
Q4 2020 Feb 12, 2021	BUY	$4.24 - $5.97 $46 - $65	11 Added 0.12%	9,000 $47,000
Q3 2020 Nov 04, 2020	BUY	$4.12 - $5.91 $12,936 - $18,557	3,140 Added 53.68%	8,989 $42,000
Q2 2020 Aug 12, 2020	BUY	$2.94 - $7.7 $3,622 - $9,486	1,232 Added 26.68%	5,849 $32,000
Q1 2020 May 04, 2020	SELL	$2.25 - $5.24 $600 - $1,399	-267 Reduced 5.47%	4,617 $16,000
Q4 2019 Feb 05, 2020	BUY	$3.08 - $5.9 $11,864 - $22,726	3,852 Added 373.26%	4,884 $20,000
Q3 2019 Nov 08, 2019	SELL	$5.25 - $9.26 $42 - $74	-8 Reduced 0.77%	1,032 $6,000
Q2 2019 Aug 13, 2019	BUY	$8.51 - $14.95 $8,850 - $15,548	1,040 New	1,040 $10,000

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.